首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1687540

血液凝固檢驗市場規模、佔有率及成長分析（按產品、檢測、技術、應用、最終用戶和地區）－2025-2032 年產業預測

Coagulation Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Test (Complete Blood Count (CBC), Factor V Assay), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月20日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年血液凝固檢驗市場規模價值 38 億美元，預計將從 2024 年的 42.6 億美元成長到 2032 年的 107.1 億美元，預測期間（2025-2032 年）的複合年成長率為 12.2%。

由於心血管疾病、血液病患病率上升和人口老化等多種因素，全球血液凝固檢驗市場正經歷強勁成長。血友病和血管性血友病等疾病的盛行率不斷上升，大大增加了對血液凝固檢驗服務的需求。此外，外科手術和創傷的增加使得及時和準確的凝血診斷變得必要。然而，嚴格的監管要求對市場動態產生了重大影響，為新參與企業帶來了挑戰。滿足品質標準和獲得監管部門的核准是市場參與企業想要在這個不斷擴張的行業中立足的關鍵因素。總體而言，在醫療保健需求不斷發展的背景下，血液凝固檢驗市場可望持續成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Abbott Laboratories（USA）
Instrumentation Laboratory（Werfen）（Spain）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（USA）
bioMerieux SA（France）
Diagnostica Stago SAS（France）
Horiba, Ltd.（Japan）
Alere Inc.（USA）（now Abbott）
Haemonetics Corporation（USA）
Helena Laboratories Corporation（USA）
Medtronic plc（Ireland）
Agilent Technologies, Inc.（USA）
Sekisui Diagnostics（Japan）
Trinity Biotech plc（Ireland）
Kyowa Medex Co., Ltd.（Japan）
Maccura Biotechnology Co., Ltd.（China）

結論和建議

簡介目錄

Product Code: SQMIG35G2268

Coagulation Testing Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.26 billion in 2024 to USD 10.71 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global Coagulation Testing Market is experiencing robust growth, fueled by various factors including the rising incidence of cardiovascular diseases, blood disorders, and an aging population. The increased prevalence of conditions like hemophilia and von Willebrand disease has significantly heightened the demand for coagulation testing services. Moreover, the escalation in surgical procedures and trauma cases necessitates timely and accurate coagulation diagnostics. However, stringent regulatory requirements highly influence the market dynamics, posing entry challenges for new players. Compliance with quality standards and obtaining regulatory approvals are critical elements for market participants hoping to establish a foothold in this expanding sector. Overall, the coagulation testing market is poised for continued growth amid these evolving healthcare demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coagulation Testing Market Segments Analysis

Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coagulation Testing Market

The rising incidence of cardiovascular diseases, along with a globally aging population, highlights the increasing demand for coagulation testing as a critical diagnostic instrument. Furthermore, technological advancements in diagnostic methods, such as optical and electrochemical coagulation testing techniques, significantly improve the precision and efficiency of results. This progress is fueling the widespread adoption of coagulation testing across various healthcare environments, making it an essential component for effective patient management. As healthcare providers seek reliable tools for diagnosing and monitoring coagulation disorders, the market for these testing methods continues to expand, reflecting the need for enhanced patient care and outcomes.

Restraints in the Coagulation Testing Market

A significant restraint in the coagulation testing market is the inherent complexities involved in standardizing testing procedures, particularly due to variations in results obtained in different laboratories and clinical environments. These discrepancies create challenges for healthcare professionals who must interpret the results accurately, potentially compromising the overall reliability of coagulation tests. Such inconsistencies not only impede effective diagnosis and treatment but also undermine confidence in testing protocols, ultimately affecting patient care. Addressing these variations is essential to enhance the consistency and accuracy of coagulation testing across diverse healthcare settings.

Market Trends of the Coagulation Testing Market

The coagulation testing market is experiencing a significant shift towards point-of-care (POC) testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This trend is primarily motivated by the need for swift decision-making in emergency situations and outpatient care settings. Technological advancements are enhancing the development of portable, user-friendly coagulation testing devices, making them easier to adopt across diverse healthcare environments. As healthcare providers seek to improve patient outcomes through timely interventions, the growing preference for POC testing is expected to shape the future landscape of the coagulation testing market, fostering innovation and expanding accessibility.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Coagulation Testing Market Size by Product & CAGR (2025-2032)

Market Overview
Instruments
Consumables
Reagents And Standards
Controls
Calibrations

Global Coagulation Testing Market Size by Test & CAGR (2025-2032)

Market Overview
Complete Blood Count (CBC)
Factor V Assay
Fibrinogen Level
Prothrombin Time
Platelet Count
Thrombin Time
Bleeding Time
Others

Global Coagulation Testing Market Size by Technology & CAGR (2025-2032)

Market Overview
Optical Technology
Mechanical Technology
Electrochemical Technology
Others

Global Coagulation Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Activated Clotting Time (ACT)
Thrombin Time (TT)
Partial Thromboplastin Time (PTT)
Activated Partial Thromboplastin Time (APTT)
Prothrombin Time (PT)
Other

Global Coagulation Testing Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others

Global Coagulation Testing Market Size & CAGR (2025-2032)

North America (Product, Test, Technology, Application, End-User)
- US
- Canada
Europe (Product, Test, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (Werfen) (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostica Stago SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA) (now Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyowa Medex Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maccura Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments